MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 228 filers reported holding MIRATI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,000 | -11.1% | 50 | 0.0% | 0.00% | – |
| Q1 2021 | $9,000 | -96.9% | 50 | -96.3% | 0.00% | -100.0% |
| Q4 2020 | $294,000 | +31.8% | 1,340 | 0.0% | 0.02% | +41.7% |
| Q3 2020 | $223,000 | +110.4% | 1,340 | +44.1% | 0.01% | +100.0% |
| Q2 2020 | $106,000 | +45.2% | 930 | -2.1% | 0.01% | +50.0% |
| Q1 2020 | $73,000 | -40.2% | 950 | 0.0% | 0.00% | -20.0% |
| Q4 2019 | $122,000 | +64.9% | 950 | 0.0% | 0.01% | +66.7% |
| Q3 2019 | $74,000 | – | 950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |